Stock Quote
AstraZeneca PLC (AZN.L) (London Stock Exchange)
2,695.00p
20 Nov 2009
-0.42%
2,706.50p
2,701.00p
3,887,989
2,717.50p
2,687.00p
2,966.00p
2,126.00p
0.43
2,717,113
AZN.L
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Schweitzer, Louis | Non-Executive Chairman of the Board | 567,000 |
| Brennan, David | Chief Executive Officer, Executive Director | 4,692,000 |
| Lowth, Simon | Chief Financial Officer, Executive Director | 2,442,000 |
Profile
AstraZeneca PLC is a United Kingdom-based pharmaceutical company, which discovers, develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for areas of healthcare, such as cardiovascular, gastrointestinal, infection, neuroscience, oncology, respiratory and... Full Description
Company Address
AstraZeneca PLC
15 Stanhope Gate
London ENG W1K 1LN
P: +4420.73045000
F: +4420.73045151
15 Stanhope Gate
London ENG W1K 1LN
P: +4420.73045000
F: +4420.73045151
Analyst Research
| AZN.L | Industry | |
|---|---|---|
| P/E(TTM) | 8.94 | 3.57 |
| P/S(TTM) | 2.01 | 0.57 |
| ROI(TTM) | 20.62 | 1.86 |
| ROE(TTM) | 40.65 | 2.51 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $4,965.67M |
| Net Income | $1,284.41M |
| EPS | $0.88 |
